Ron receptor tyrosine kinase signaling as a therapeutic target - Wikidata - wikimedia - TriplyDB

Ron receptor tyrosine kinase signaling as a therapeutic target

Ron receptor tyrosine kinase signaling as a therapeutic target

http://www.wikidata.org/entity/Q27003295

about

An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in mice A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.Autoinhibition of the Ron receptor tyrosine kinase by the juxtamembrane domain.HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling.RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation

P2860

Q27690294-ABD0537A-8738-4CF0-916C-F044E899D28C Q27865272-7DDEF933-1CA7-417D-BEC2-8137B860BA60 Q35273848-4C0086D5-7D30-4413-86F8-90ED82071875 Q36814075-8EA42536-53FA-46E4-A127-6B9C7B4EA610 Q39628474-68B04871-B401-4906-8AB5-40F6F4BEB0C8 Q41708922-404910EC-4A83-4F46-BF47-1655CBA39E87 Q53591553-0A934573-A2EC-4849-9F66-1DFD4EA9DD98 Q58777826-45D83B52-C2E5-49F4-9D3D-5A8764E569A6

P2860

Ron receptor tyrosine kinase signaling as a therapeutic target

http://www.wikidata.org/entity/Q27003295

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Ron receptor tyrosine kinase signaling as a therapeutic target

@ast

Ron receptor tyrosine kinase signaling as a therapeutic target

@en

Ron receptor tyrosine kinase signaling as a therapeutic target

@nl

type

label

Ron receptor tyrosine kinase signaling as a therapeutic target

@ast

Ron receptor tyrosine kinase signaling as a therapeutic target

@en

Ron receptor tyrosine kinase signaling as a therapeutic target

@nl

prefLabel

Ron receptor tyrosine kinase signaling as a therapeutic target

@ast

Ron receptor tyrosine kinase signaling as a therapeutic target

@en

Ron receptor tyrosine kinase signaling as a therapeutic target

@nl

P1433

Q27003295-D4720378-8CBB-422A-BDEB-8AEB0516817D

P1476

Q27003295-49C7D9A4-A9D4-491C-80A0-B9F7E10F6882

P2093

Q27003295-ADC34A8B-FB79-4695-8D3C-F5B51941A5C8

Q27003295-CC7710ED-2FF3-46E0-93EA-297B7779F4EB

P2860

Q27003295-001DB503-5443-450B-982E-AE7E1D8E1856

Q27003295-039D0E64-05B4-41B0-842D-7FCF66A5A645

Q27003295-042B6A47-7E41-4659-8E82-57796395D377

Q27003295-049A049B-1D8A-45F2-BB62-DE4E991D5109

Q27003295-080AEE17-C090-4FBD-ABFD-5383D30665AA

Q27003295-128410A0-A5FA-4770-874E-B6BC2FBCB66C

Q27003295-1A28DBE3-8710-4196-A766-6141E14DDA3E

Q27003295-1C6DF3C8-247F-4341-B300-9D9B215D0792

Q27003295-1CF20ACE-64E6-4923-9145-0A429F0360E6

Q27003295-226CC59A-B75B-46A2-B8AF-417C1DBCF86F

P304

Q27003295-DB14B9BA-18C6-4CB9-8F8E-638EC6744210

P31

Q27003295-525AD770-D267-4DAA-86B9-12FABAB74A88

P356

Q27003295-AC11C5A3-3FDF-42ED-8214-B8FB3832B7AD

P407

Q27003295-F63CB516-B2A5-4250-9EA6-4D94259B4613

P433

Q27003295-DAE46456-504D-4431-8F71-370DF9EB1660

P478

Q27003295-60EEC757-1E2A-41DD-BA4A-B3C10F692099

P50

Q27003295-B5F3DC86-7697-4B20-BB52-A6E4C21CA496

Q27003295-EC581F4A-DD37-443C-A72A-BCE16D44ABFA

P577

Q27003295-ADA87B81-84A8-4C6C-92B2-C36007CE1FA1

P698

Q27003295-1B12F362-DC81-40F5-BFE1-32FA54E87209

P932

Q27003295-84672B04-6F65-4D5D-915C-B55037B28C80

P356

14728222.2012.710200

P1433

Expert Opinion on Therapeutic Targets

P1476

Ron receptor tyrosine kinase signaling as a therapeutic target

@en

P2093

Nancy M Benight

http://www.w3.org/2001/XMLSchema#string

Susan E Waltz

http://www.w3.org/2001/XMLSchema#string

P2860

Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitution

Identification of the ron gene product as the receptor for the human macrophage stimulating protein

STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family

RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP

A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype

Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases

Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade

The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration

A novel putative receptor protein tyrosine kinase of the met family

Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor

P304

921-931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2012.710200

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Nancy M Benight

P577

2012-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22834780

http://www.w3.org/2001/XMLSchema#string

P932

4075176

http://www.w3.org/2001/XMLSchema#string